2019 Summary Report On Antimicrobials Sold or Distributed for Use in Food-Producing Animals

  17 December 2020

Each year, every sponsor of an approved or conditionally approved animal drug application containing an antimicrobial active ingredient must report to the Food and Drug Administration (FDA) the amount of each such ingredient in these drug products sold or distributed for use in food-producing animals. FDA summarizes this information and makes it available to the public in annual summary reports. This reporting requirement was enacted by Congress in 2008 to assist FDA in its continuing analysis of the interactions (including antimicrobial resistance), efficacy, and safety of antimicrobials approved for use in both humans and food-producing animals.

This summary report presents the sales and distribution data for actively marketed antimicrobial drugs approved for use in food-producing animals by drug class, medical importance, route of administration, indication, and dispensing status, as well as species-specific estimates, of sales and distribution from 2010 through 2019.

Author(s): FDA Center for Veterinary Medicine
Healthy Animals  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!